The GLP-1 market is growing fast. Here’s how much the most popular medications will cost you.

Medically reviewed by Lindsay Cook, PharmD GLP-1 medications are now available as both pills and injections, offering more ...

People shouldn’t buy or use unauthorized, injectable peptide drugs claiming to help with body issues and wellness, warns ...

Public advisory - Think twice before injecting peptides bought online: unauthorized products can seriously harm you ...

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection. Patients with a prescription could obtain the starter 1.5 mg dose of the tablet ...

Drugmakers Novo Nordisk and Eli Lilly and Company have transformed the landscape of chronic weight loss management with the ...

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

On January 5, 2026, Novo Nordisk announced it had launched an oral tablet version of its injectable GLP-1 weight-loss medication, Wegovy (semaglutide). The GLP-1 pill is still prescription-only, but ...

Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for ...